Comparison

TRK-IN-13 European Partner

Item no. HY-146518-1ea
Manufacturer MedChem Express
CASRN 1365221-52-8
Amount 1 ea
Category
Type Chemicals
Specific against other
Formula C24H21F2N5O
Citations [1]Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1.
Smiles O=C(C1=CN=C2C=CC(N3CCCC3C4=CC(F)=CC=C4)=NN21)NCC5=CC=C(C=C5)F
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
TRK-IN-13 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-13 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-24)[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
433.45
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Manufacturers Target
Trk Receptor
Pathway
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close